FDA, but puppets on the end of big pharma string. MSB got shafted.
However, SI is made of tough stuff and is in for the long haul.
Patience.
I still think Crohns will become the cash cow, whilst SI chokes FDA into submission on agvhd, right down at the end in the same dark dank corner that only rats reside.
( call me bitter)
Cell Therapy News/Articles, page-17288
-
- There are more pages in this discussion • 533 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |